Artiva Biotherapeutics, Inc. ARTV
4.22 USD +0.02 (+0.48%)
At closeNov 4, 2026, 4:29 PM EST
4.19 -0.03 -0.71%
After hours · Nov 4, 4:29 PM ET
4.16 Day range 4.27
2.96 52-week range 14.53
- YTD
- -1.63%
- 1 year
- +17.55%
Analyst view
Price target (mean) 21.25 +403.6% upside
Now 4.22
- Target (low)
- 18.00
- Target (mean)
- 21.25
- Target (high)
- 23.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy1
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.58 | -0.58 – -0.58 | 0.00 | 0.0% | 60.00K | 0.0% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | -5.08 | -5.08 – -5.08 | 0.00 | 0.0% | 270.40K | 0.0% | 1 |
| Next year | -2.61 | -2.61 – -2.61 | -5.08 | +48.6% | 0 | -100.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 13, 2024 | Needham | Reiterated | Buy | Buy |
| Aug 30, 2024 | Needham | Reiterated | Buy | Buy |
| Aug 13, 2024 | Needham | Initiated | — | Buy |
| Aug 13, 2024 | Wedbush | Initiated | — | Outperform |
| Aug 13, 2024 | Cantor Fitzgerald | Initiated | — | Overweight |
| Aug 13, 2024 | TD Cowen | Initiated | — | Buy |
| Aug 13, 2024 | Jefferies | Initiated | — | Buy |